BRPI0823391B8 - composições fitoestrogênicas, uso das mesmas para prevenção ou tratamento de sintomas associados com menopausa - Google Patents

composições fitoestrogênicas, uso das mesmas para prevenção ou tratamento de sintomas associados com menopausa

Info

Publication number
BRPI0823391B8
BRPI0823391B8 BRPI0823391A BRPI0823391A BRPI0823391B8 BR PI0823391 B8 BRPI0823391 B8 BR PI0823391B8 BR PI0823391 A BRPI0823391 A BR PI0823391A BR PI0823391 A BRPI0823391 A BR PI0823391A BR PI0823391 B8 BRPI0823391 B8 BR PI0823391B8
Authority
BR
Brazil
Prior art keywords
menopause
phytoestrogenic
compositions
symptoms associated
treating
Prior art date
Application number
BRPI0823391A
Other languages
English (en)
Inventor
Kwak Bo-Yeon
Kim Jae-Soo
Lee Jaekyoung
Yi Kwontaek
Original Assignee
Natural Endotech Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Endotech Co Ltd filed Critical Natural Endotech Co Ltd
Publication of BRPI0823391A2 publication Critical patent/BRPI0823391A2/pt
Publication of BRPI0823391B1 publication Critical patent/BRPI0823391B1/pt
Publication of BRPI0823391B8 publication Critical patent/BRPI0823391B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

composições fitoestrogênicas para prevenção ou tratamento de sintomas associados com menopausa. a presente invenção refere-se a uma composição farmacêutica para prevenção ou tratamento de um distúrbio de menopausa, compreendendo ácido cinâmico, shanzhiside metiléster ou uma mistura dos mesmos como um ingrediente ativo. a composição da presente invenção exibe uma excelente atividade estrogênica, e é eficazmente utilizada para tratamento ou prevenção de distúrbio diversos de menopausa gerados por redução de estrogênio durante perimenopausa, menopausa e pós-menopausa.
BRPI0823391A 2008-12-26 2008-12-26 composições fitoestrogênicas, uso das mesmas para prevenção ou tratamento de sintomas associados com menopausa BRPI0823391B8 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2008/007697 WO2010074361A1 (en) 2008-12-26 2008-12-26 Phytoestrogenic compositions for preventing or treating symptoms associated with menopause

Publications (3)

Publication Number Publication Date
BRPI0823391A2 BRPI0823391A2 (pt) 2015-06-16
BRPI0823391B1 BRPI0823391B1 (pt) 2019-06-18
BRPI0823391B8 true BRPI0823391B8 (pt) 2021-05-25

Family

ID=42287937

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0823391A BRPI0823391B8 (pt) 2008-12-26 2008-12-26 composições fitoestrogênicas, uso das mesmas para prevenção ou tratamento de sintomas associados com menopausa

Country Status (12)

Country Link
US (1) US9433595B2 (pt)
EP (1) EP2370072B1 (pt)
CN (1) CN102264362B (pt)
AU (1) AU2008365666B2 (pt)
BR (1) BRPI0823391B8 (pt)
CA (1) CA2745020C (pt)
ES (1) ES2641291T3 (pt)
MX (1) MX2011005835A (pt)
MY (1) MY184493A (pt)
PL (1) PL2370072T3 (pt)
RU (1) RU2491926C2 (pt)
WO (1) WO2010074361A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101698051B1 (ko) * 2016-01-13 2017-01-20 아주대학교산학협력단 로가닌 또는 이의 유도체를 유효성분으로 함유하는 여성 갱년기 증후군 예방, 개선 또는 치료용 조성물
RU2736997C1 (ru) * 2019-07-30 2020-11-23 Общество С Ограниченной Ответственностью "Парафарм" Средство для лечения приливов и восстановления менструального цикла в период перименопаузы и способ его применения
KR102697110B1 (ko) 2020-12-07 2024-08-22 킴벌리-클라크 월드와이드, 인크. 대사산물을 검출하기 위한 방법 및 소비자 제품
CN115671217B (zh) * 2022-11-25 2023-08-01 长春中医药大学 一种治疗绝经前后诸证的中药配方

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
US6660283B2 (en) * 1997-12-19 2003-12-09 Societe L'oreal S.A. Use of cinnamic acid, or of at least one of its derivatives in a cosmetic composition
FR2772612B1 (fr) * 1997-12-19 2003-01-10 Oreal Utilisation de l'acide cinnamique ou de ses derives dans une composition cosmetique raffermissante
CN1303671A (zh) * 1999-11-26 2001-07-18 深圳市御康实业有限公司湖南省分公司 肉桂酸用于制备治疗糖尿病的药物
WO2002032438A1 (en) * 2000-09-13 2002-04-25 Jiangsu Kanion Pharmaceutical Co. Pharmaceutical composition treating gynecological blood stasis diseases, cardio and cerebral vascular diseases, respiratory diseases and the like
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
US6664236B2 (en) * 2002-03-19 2003-12-16 Council Of Scientific And Industrial Research Synergistic composition of bioactive fraction isolated from barleria prionitis linn and a method of treatment for hepatotoxicity, immuno-deficiency and fatigue and a process thereof
KR100740566B1 (ko) * 2006-03-13 2007-07-18 경희대학교 산학협력단 페닐프로파노이드 계 화합물을 포함하는 항불안 및 기억력개선 효과를 나타내는 조성물
KR20080093203A (ko) * 2007-04-16 2008-10-21 경희대학교 산학협력단 알기닌, 신남산, 다이드진, 푸에라린, 팔마틴, 베르베린또는 베타-디-글루코피라노사이드로부터 선택된 화합물을유효성분으로 함유하는 골절 질환의 예방 및 치료용 조성물

Also Published As

Publication number Publication date
US20110251145A1 (en) 2011-10-13
RU2011130246A (ru) 2013-02-10
US9433595B2 (en) 2016-09-06
EP2370072B1 (en) 2017-06-28
CN102264362A (zh) 2011-11-30
EP2370072A1 (en) 2011-10-05
CN102264362B (zh) 2013-10-23
MX2011005835A (es) 2011-07-04
AU2008365666B2 (en) 2013-05-23
PL2370072T3 (pl) 2017-12-29
BRPI0823391A2 (pt) 2015-06-16
EP2370072A4 (en) 2012-09-05
CA2745020C (en) 2013-10-15
MY184493A (en) 2021-04-01
BRPI0823391B1 (pt) 2019-06-18
AU2008365666A1 (en) 2011-07-07
ES2641291T3 (es) 2017-11-08
WO2010074361A1 (en) 2010-07-01
RU2491926C2 (ru) 2013-09-10
CA2745020A1 (en) 2010-07-01

Similar Documents

Publication Publication Date Title
PH12015501404A1 (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
PH12012501480A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
BR112015001419A2 (pt) composto, composição farmacêutica, e, métodos para inibir romk em um paciente, para causar diurese, natriurese ou ambos e para tratamento de um ou mais distúrbios
BRPI0510074A (pt) composições farmacêuticas para o tratamento de distúrbios sexuais ii
MX2014002459A (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodos de uso de los mismos.
BR112012021364A2 (pt) "compostos cicloalquila contendo tienopirimidinas e composições farmacêuticas".
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
BR112012002578B8 (pt) usos de treprostinil ou de um derivado ou de um sal farmaceuticamente aceitável do mesmo para tratamento da fibrose cística
BR112014004741A2 (pt) pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
BR112014010417A2 (pt) Métodos para o tratamento de cânceres com o uso de formulações orais de análogos de citidina
GT201200281A (es) Formas de dosificación sólidas orales con dosis muy bajas para la hrt
PH12014500239A1 (en) Certain kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof
CL2007002272A1 (es) Compuestos derivados de n-metil-c-normorfinano; composicion farmaceutica; y uso para la reduccion de efectos secundarios del tratamiento de opioides tales como constipacion y nauseas, y para tratar trastornos mediados por la actividad de receptores o
BR112012018765A2 (pt) agente profilático ou terapêutico para as doenças do trato biliar
WO2008116890A3 (en) Pharmaceutical compositions comprising flibanserin and a further agent in the treatment of sexual disorders
PH12013500293A1 (en) Methods of treating alcohol intoxication, alcohol use disorders and alcohol abuse which comprise the administration of dihydromyricetin
BR112012015202A2 (pt) "iota - e/ou kappa-carrgenado junto com um inibidor da neuraminidase, método para o tratamento profilático ou terapêutico de um sintoma, condição ou doença, composição farmacêutica,e, kit de partes".
UY33530A (es) Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias
BR112013033008A8 (pt) composição farmacêutica líquida compreendendo nitisinona
BR112015019802A2 (pt) formulações farmacêuticas de nitrito e usos das mesmas
BRPI0916232A2 (pt) Moduladores do receptor de esfingosina-1-fosfato e seu uso para tratar inflamação muscular
BR112014030325A8 (pt) uso de composição contendo derivado de verbenona para a obtenção de produto destinado ao tratamento ou prevenção de doença cerebral degenerativa, alimento funcional para prevenir ou tratar doença neurodegenerativa e composto
BRPI0823391B8 (pt) composições fitoestrogênicas, uso das mesmas para prevenção ou tratamento de sintomas associados com menopausa
BR112013004562A2 (pt) 2-óxi-quinolina-3-carboxamidas substituídas como moduladores kcnq2/3
BR112014031649A8 (pt)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/06/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/06/2019, OBSERVADAS AS CONDICOES LEGAIS

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 26/12/2008 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF